Your browser doesn't support javascript.
loading
GuiErBai: a potent inhibitor, exhibiting broadly antitumor effect against cervical cancer in vitro and in vivo.
Qin, Hong-En; Peng, Lei; Xu, Yuan-Cui; Zhang, Zi-Xiong; Tian, Ren-Fu; Wan, Zhong-Xian; Pu, Dao-Jing; Li, Hong-Chun; Wu, Fei; Zheng, Liangdong; Xu, Xian-Shun.
Affiliation
  • Qin HE; Department of Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
  • Peng L; Department of Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
  • Xu YC; Department of Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
  • Zhang ZX; Department of Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
  • Tian RF; Department of Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
  • Wan ZX; Department of Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
  • Pu DJ; Department of Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
  • Li HC; Department of Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
  • Wu F; Department of Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
  • Zheng L; Department of Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
  • Xu XS; Department of Medicine, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, Hubei, China.
Front Pharmacol ; 15: 1296588, 2024.
Article in En | MEDLINE | ID: mdl-38915466

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2024 Document type: Article Affiliation country: China Country of publication: Suiza

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Pharmacol Year: 2024 Document type: Article Affiliation country: China Country of publication: Suiza